Outcome of Autologous Hematopoietic Stem Cell Transplantation in Refractory Multiple Myeloma

BACKGROUND: Despite the introduction of effective novel agents, the outcome of patients with refractory multiple myeloma remains poor, particularly those refractory to both proteasome inhibitors (PIs) and immunomodulatory agents (IMiDs). Limited data is available on the role of autologous hematopoie...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer
Hlavní autoři: Veltri, Lauren W., Milton, Denái R., Delgado, Ruby, Shah, Nina, Patel, Krina, Nieto, Yago, Kebriaei, Partow, Popat, Uday R., Parmar, Simrit, Oran, Betul, Ciurea, Stefan, Hosing, Chitra, Lee, Hans C., Manasanch, Elisabet, Orlowski, Robert Z., Shpall, Elizabeth J., Champlin, Richard E., Qazilbash, Muzaffar H., Bashir, Qaiser
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5656242/
https://ncbi.nlm.nih.gov/pubmed/28513828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30770
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky